NeuroPace (NPCE) Operating Leases (2022 - 2026)

NeuroPace's Operating Leases history runs 5 years deep, the most recent figure standing at $9.3 million for Q1 2026.

• On a quarterly basis, Operating Leases fell 19.11% year-over-year to $9.3 million in Q1 2026; TTM through Mar 2026 was $9.3 million, a 19.11% decrease from a year earlier, with the FY2025 full-year figure at $9.8 million, down 17.71% from the prior year.
• Operating Leases eased to $9.3 million in Q1 2026 per NPCE's latest filing, from $9.8 million in the prior quarter.
• Across five years, Operating Leases topped out at $16.5 million in Q1 2023 and bottomed at $6.2 million in Q2 2022.
• The 5-year median for Operating Leases is $13.4 million (2024), against an average of $12.7 million.
• Across the five-year window, Operating Leases soared 162.43% in 2023 and fell 19.11% in 2026, its largest moves.
• Year by year, Operating Leases stood at $15.4 million in 2022, then fell by 10.53% to $13.8 million in 2023, then declined by 13.47% to $12.0 million in 2024, then retreated by 17.71% to $9.8 million in 2025, then slipped by 5.91% to $9.3 million in 2026.
• Per Business Quant, the three latest NPCE Operating Leases figures stand at $9.3 million (Q1 2026), $9.8 million (Q4 2025), and $12.4 million (Q3 2025).